- Home
- EDSA vs FLGC Comparison
EDSA vs FLGC Comparison
Compare EDSA & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- FLGC
- Stock Information
- Founded
- EDSA 2015
- FLGC 2019
- Country
- EDSA Canada
- FLGC United States
- Employees
- EDSA N/A
- FLGC N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- EDSA Health Care
- FLGC Health Care
- Exchange
- EDSA Nasdaq
- FLGC Nasdaq
- Market Cap
- EDSA 15.9M
- FLGC 15.9M
- IPO Year
- EDSA N/A
- FLGC 2021
- Fundamental
- Price
- EDSA $2.11
- FLGC $20.60
- Analyst Decision
- EDSA Strong Buy
- FLGC Buy
- Analyst Count
- EDSA 2
- FLGC 2
- Target Price
- EDSA $13.00
- FLGC $156.00
- AVG Volume (30 Days)
- EDSA 38.0K
- FLGC 12.0K
- Earning Date
- EDSA 08-08-2025
- FLGC 08-01-2025
- Dividend Yield
- EDSA N/A
- FLGC N/A
- EPS Growth
- EDSA N/A
- FLGC N/A
- EPS
- EDSA N/A
- FLGC N/A
- Revenue
- EDSA N/A
- FLGC $52,373,000.00
- Revenue This Year
- EDSA N/A
- FLGC N/A
- Revenue Next Year
- EDSA N/A
- FLGC N/A
- P/E Ratio
- EDSA N/A
- FLGC N/A
- Revenue Growth
- EDSA N/A
- FLGC N/A
- 52 Week Low
- EDSA $1.55
- FLGC $15.15
- 52 Week High
- EDSA $5.18
- FLGC $82.29
- Technical
- Relative Strength Index (RSI)
- EDSA 42.63
- FLGC 43.46
- Support Level
- EDSA $2.02
- FLGC $16.08
- Resistance Level
- EDSA $2.35
- FLGC $21.60
- Average True Range (ATR)
- EDSA 0.14
- FLGC 2.85
- MACD
- EDSA -0.03
- FLGC -0.44
- Stochastic Oscillator
- EDSA 18.00
- FLGC 48.43
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.